Usefulness of biological markers in the early prediction of corona virus disease-2019 severity

References

• Gong J, Jingyi O, Xueping Q, et al. A tool for early prediction of severe coronavirus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis. 2020;71(15):833–840.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhicheng Z, Jie T, et al. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus. Ann Palliat Med. 2020;9(2):428–436.
   PubMed Web of Science ®Google Scholar
• Wang D, Bo H, Chang H, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
   PubMed Web of Science ®Google Scholar
• Chen T, Di W, Huilong C, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.
   PubMed Web of Science ®Google Scholar
• Huang C, Yeming W, Xingwang L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Gao Y, Tuantuan L, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19. J Med Virol. 2020;92(7):791–796.
   PubMed Web of Science ®Google Scholar
• Soraya GV, Ulhaq e. Z S. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: an updated meta-analysis. Medicina Clinica. 2020;155(4):143–151.
   PubMed Web of Science ®Google Scholar
• Liu J, Yao L, Pan X, et al. Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage. J Transl Med. 2020;18(1):206.
   PubMed Web of Science ®Google Scholar
• Henry BM, Maria HS, Stefanie B, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–1028.
   PubMed Web of Science ®Google Scholar
• Tan L, Qi W, Duanyang Z, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Sig Transduct Target Ther. 2020;5(1):33.
   PubMed Web of Science ®Google Scholar
• Ministère de la Santé de la Population et de la Réforme Hospitalière avec la contribution du Ministère de la Poste et des Télécommunications. 2020. Available from: http://covid19.sante.gov.dz/fr/accueil/.
   Google Scholar
• Gorbalenya AE, Susan C, Baker Ralph S, et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses – a statement of the coronavirus study group. Nat Microbiol. 2020;5:536–544.
   PubMed Web of Science ®Google Scholar
• Guan W, Zheng-Yi N, Yu H, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Yang X, Yuan Y, Jiqian X, et al. Clinical course and outcomes of critically Ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481.
   PubMed Web of Science ®Google Scholar
• Li X, Shuyun X, Muqing Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118.
   PubMed Web of Science ®Google Scholar
• Wang L, Xun L, Hui C, et al. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol. 2020;51(5):343–348.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Ran L, Kun W, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Jia J, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26(6):767–772.
   PubMed Web of Science ®Google Scholar
• Yuan J, Rougrong Z, Lijiao Z, et al. The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflamm Res. 2020;69(6):599–606.
   PubMed Web of Science ®Google Scholar
• Qin C, Luoqi Z, Ziwei H, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhao-Wu T, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020;133(9):1032–1038.
   PubMed Web of Science ®Google Scholar
• Terpos E, Ioannis NS, Ismail E, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–847.
   PubMed Web of Science ®Google Scholar
• Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. 2020;35(3):266–271.
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943.
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Adrover JM, Amelia BS, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. JCI Insight. 2020;217(6):e20200652.
   Google Scholar
• Li X, Luwen W, Shaonan Y, et al. Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis. 2020;94:128–132.
   PubMed Web of Science ®Google Scholar
• Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect. 2020;50(4):332–334.
   PubMed Web of Science ®Google Scholar
• Zhou F, Ting Y, Ronghui D, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 2020;58(7):1063–1069.
   PubMed Web of Science ®Google Scholar
• Goldberg A, Hammerman H, Petcherski S, et al. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction. Am J Med. 2004;117(4):242–248.
   PubMed Web of Science ®Google Scholar
• Lazzeri C, Serafina V, Marco C, et al. Usefulness of hyponatremia in the acute phase of ST-elevation myocardial infarction as a marker of severity. Am J Card. 2012;110(10):1419–1424.
   PubMed Web of Science ®Google Scholar